Newsroom

TOKYO--(BUSINESS WIRE)--Hibiki Path Advisors (“we”, “us”, “our”) has decided to launch a public campaign, including shareholder proposals, directed at one of our portfolio companies, JAPAN PURE CHEMICAL CO., LTD. (Securities Code: 4973) (hereinafter referred to as “the Company”, “JPC”), in the lead-up to its 54th Annual General Meeting of Shareholders scheduled for 20th June 2025. As the largest shareholder of the Company, our aim with this campaign is to protect and enhance the common interest...

TOKYO--(BUSINESS WIRE)--（ビジネスワイヤ） -- Hibiki Path Advisors（以下、「私ども」といいます。）は、投資先の一社である日本高純度化学株式会社(証券コード：4973)（以下、「当社」といいます。）に対し、2025年6月20日開催予定の第54期株主総会に向けて、筆頭株主の立場から当社全株主共同の利益を確保するべく、株主提案を含む公開キャンペーンを実施する事を決定いたしました。 当社が上程する渡辺取締役相談役の再任への反対 尚、その他取締役候補につき、小島智敬氏、黒松百亜氏を除く８名（補欠を含む）に対し反対を予定（※１） 当社が上程する監査等委員会設置会社への移行への反対を予定（※1） 株主提案（第10号議案）：取締役(社外取締役を除く)に対する株式報酬の強化 株主提案（第11号議案）：剰余金の配当等の決定機関に関する定款一部変更の件 株主提案（第12号及び13号議案）：ROE向上に向けた株主還元の強化（自己株式取得、配当の強化） ※１ ①及び②に関して予定としている理由については、添付趣意書をご参照下さい。 尚、公開キャンペーンの詳細につ...

SHANGHAI & CAMBRIDGE, Mass. & BAAR, Switzerland--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of Tumor Treating Fields (TTFields) therapy for pancreatic cancer will be presented today at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago and simultaneously published in the Journal of Clinical Oncology. “The data presented today from the PANOVA-3 trial of Tumor Treating...

BEIJING--(BUSINESS WIRE)--Avistone Announces Encouraging Results for Vebreltinib plus PLB1004 in EGFR-mutated NSCLC with MET Amplification or Overexpression...

PHOENIX--(BUSINESS WIRE)--University of Phoenix honored its annual Faculty of the Year Award recipients at an awards ceremony event held Saturday, May 17, at the Royal Palms Resort in Phoenix, Arizona. The Faculty of the Year Award is part of the Faculty Rewards & Recognition Program at University of Phoenix (UOPX). Each year, the university announces a nomination period and asks students, employees and faculty to nominate UOPX faculty for the award. The awards ceremony was part of a series...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of BioSig Technologies, Inc. (NasdaqCM: BSGM) and Streamex Exchange Corporation. Upon closing of the proposed transaction, current BioSig shareholders and holders of common stock equivalents will hold 25% of the fully diluted BioSig common stock outstanding. KSF is seeking to determine whether the me...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Heliogen, Inc. (OTC: HLGN) to Zeo Energy Corp. (NasdaqCM: ZEO). Under the terms of the proposed transaction, shareholders of Heliogen will receive shares of Zeo’s Class A common stock valued at approximately $10 million in the aggregate, based on a Zeo Class A common stock price of $1.5859 per share...

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Signing Day Sports, Inc. (NYSE: SGN) and One Blockchain LLC. Upon closing of the proposed transaction, Signing Day shareholders are expected to own approximately 8.5% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whethe...

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Broadmark business and prospects resulting in its stock trading at inflated prices....

SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning UroGen business and prospects resulting in its stock trading at inflated prices....